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Abstract
Designing bone scaffolds containing both organic and inorganic composites simulating the architecture of the
bone is the most important principle in bone tissue engineering. The objective of this study was to fabricate a
composite scaffold containing poly (D, l)-lactide (PDLLA) and β-tricalcium phosphate (β-TCP) as a platform for
osteogenic differentiation of adipose-derived mesenchymal stem cells. In this study, PDLLA/β-TCP scaffolds were
fabricated using three-dimensional printing (3D) technology through melt excursion technique. The
physicomechanical characteristics, including microstructure, mechanical properties, of the customized scaffolds
were investigated. Further, the in vitro biological characteristics of manufactured scaffolds were evaluated in
conjugation with buccal fat pad derived mesenchymal stem cells in terms of cell attachment, viability,
proliferation, and osteogenic differentiation capacity. The 3D printed customized scaffold in this study showed
proper pore size, porosity, mechanical strength, material composition, biocompatibility, and osteogenic
differentiation capacity. The obtained results converge to reveal the promising features of the nanocomposite
3D printed platform for personalized bone tissue engineering.
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1. Introduction
Designing bone scaffolds mimicking the natural structure of bone tissues is the most important principle in bone
tissue engineering. The synthesis of scaffold containing both organic and inorganic composites simulating the
architecture of the bone, which can be regarded as a polymer and ceramic composites, has been extensively
investigated by several studies [1].The absorbable polymers lactic acid-based, such as poly(D, l)-lactide (PDLLA),
have been widely used, which is due to their biodegradability and biocompatibility [[2], [3], [4], [5]]. However,
the relatively low mechanical properties of pure polymer makes them improper for reconstruction of loadbearing areas [6,7]. Besides, the degradation of PDLLA creates the acidic environment next to the implant site
which results in inflammatory reactions and prevents a complete degradation of the implant [2,5,8]. The βtricalcium phosphate (β-TCP) is one of the most comprehensively investigated biocompatible ceramics that used
in medical applications [2,4,9]. Studies have shown that β-TCP is a biocompatible and osteoconductive material
with bone bonding capacity but have a limited degradability [4,[10], [11], [12], [13], [14], [15]].
Hence, the combing these materials would be beneficial in such each component has a specific function [2,3,16].
Studies have shown that incorporation of bioceramic, β-TCP, with polymer, PDLLA, lead to composite scaffold
having improved mechanical properties as well as controllable degradation rates [3,17]. However, various
percentage of β-TCP has been used in corporation with PDLLA in composite scaffolds [[2], [3], [4],18]. Despite
the effect of ceramic materials in enhancement of mechanical properties of a composite scaffold as well as their
significant effect in promotion of bone regeneration [3], lower percentage of ceramic component lead to
fabricate a scaffold with desirable degradation rates [18,19].
Apart from scaffold materials, shape and microstructure of a scaffold is highly important. Various studies have
shown that the appropriate bone healing is the result of the osseointegration between bone and scaffolds which

in turn is the consequence of matching the bone graft with defect [2,9]. The new additive manufacturing
technologies including three-dimensional printing (3D), lead to design and fabricate of a scaffold matching
desirable individual shape and proper internal structures [[20], [21], [22]]. Comparing to conventional methods,
porous scaffolds could be fabricated like bone structure to create the porosity and interconnected pores [9,17].
Interconnected pores allow nutrients and molecules to transport to inner parts of a scaffold to facilitate cell
migration, cell ingrowth, vascularization, continuous ingrowth of bone tissue, as well as waste material removal
[4,23,24].
Given that, the objective of this study was to fabricate a composite scaffold containing PDLLA and β-TCP using a
3DP technology with the lower percentage of β-TCP (40% β-TCP vs 60% PDLLA), which has been less studied
before. Then, the fabricated scaffolds, were first characterized for their physicomechanical properties in order to
evaluate if their properties match natural bone structure. Secondly, their biological properties, including
biocompatibility and osteogenic differentiation, were investigated after loading with adipose-derived
mesenchymal stem cells from buccal fat pad (BFPSCs), in order to investigate the possible application in
preclinical bone regeneration application.

2. Materials and methods
2.1. Fabrication of PDLLA and PDLLA/ß-TCP scaffolds by 3D printing

PDLLA/β-TCP composite was prepared using solvent casting method. Briefly, 2g PDLLA (PURASORB, Corbion) was
dissolved in 20 ml Dichloromethane (Alfa Aesar), and 600 mg β-TCP (Sigma-Aldrich) was then added to the
polymer solution and stirred using a magnet-stirrer for 2 h. The resultant mixture was then cast onto clean petri
dishes and dried at room temperature. Finally, the cast PDLLA/β-TCP 30 wt% films were incubated overnight in a
vacuum oven to be fully dried.
PDLLA and PDLLA/β-TCP scaffolds were printed through the melt extrusion technique using a commercial
bioprinting system (3D-Bioplotter Manufacturer Series, EnvisionTEC). PDLLA and PDLLA/β-TCP composites were
loaded in a steel cylinder which was sealed and inserted into a high temperature head of the machine. The
system was purged and pressurized with nitrogen stream. The temperature of the head was set to 170°C and
incubated for 10 min prior printing to be equilibrated. Scaffolds with square block models of 7 × 7 × 7 mm3 were
designed using the Bioplotter CAD/CAM software (EnvisionTEC) Scaffolds were printed layer-by-layer with 0.8
mm distance between strands and a 90- degree shift between layers extruded from a nozzle with 0.4 mm inner
diameter.
The pressure and dispensing speed were optimized at 2.0 bar, 5 mm/s and 2.5 bar, 4 mm/s for PDLLA and
PDLLA/β-TCP scaffolds, respectively. It should be noticed that the pressure and speed of printing for PDLLA and
PDLLA/β-TCP scaffolds were adjusted to achieve scaffolds with similar microstructure and pore size.

2.2. Physicomechanical characterization
2.2.1. Fourier transform infrared spectroscopy (FTIR) analysis
PDLLA/β-TCP composite scaffolds were characterized using a Nicolet™ iS5 FTIR Spectrometer (iD5 Diamond
Attenuated total reflection) with the scan number of 16 and resolution of 4 cm-1. Samples were analyzed in
4000–550 cm-1 wavenumber range and transmittance mode.

2.2.2. Differential scanning calorimetry (DSC) analysis
The thermal properties of PDLLA and PDLLA/β-TCP scaffolds were investigated by differential scanning
calorimetry method (DSC, NETZSCH DSC 404F1 Pegasus®) All measurements were carried out with about 10 mg
sample in aluminum crucibles with pierced lid under ultra-pure argon ﬂow of 20 ml min-1 with the heating rate

of 10 °C min-1. Prior to DSC measurements, samples were first heated up to 70 °C at the rate of 10 °C min-1, and
then cooled down to room temperature at the rate of 3 °C min-1.

2.2.3. Evaluation of mechanical properties
Mechanical properties of fabricated scaffolds were determined at 25 °C in compression mode using a universal
testing machine (AGS-X series, Shimadzu, Japan) with a 5 KN load cell at a speed of 1 mm/min. The samples (n =
5) with the size of 7 × 7 × 14 (W × L × H) mm3 were compressed in Z direction. The compression was continued
until the samples were fractured. Elastic moduli were derived from the initial linear region of the stress–strain
curves.

2.2.4. Pore size measurement
The size of pores in 3D printed scaffolds (n = 3) was measured by means of laser scanning microscopy. The 3D
printed PDLLA and PDLLA/β-TCP scaffolds were scanned for their microstructure using the LEXT OLS4000 3D
Laser Measuring Microscope (Olympus LEXT OLS 4000, Japan)

2.2.5. Porosity measurement
The porosity of scaffolds was measured based on liquid displacement method [[25], [26], [27]]. In brief, scaffold
specimens were first weighed (Wi), and then immersed in a predetermined volume of ethanol (V1) at 25 °C for
10 min to ensure complete wetting. Subsequently, the volume of the ethanol after immersion of the scaffold
was measured (V2) to calculate the volume of the scaffold (V2–V1). Based on the initial (Wi) and final (Wf) weights
of the scaffolds after soaking in ethanol, the pore volume of scaffolds can be achieved as (Wf−Wi)/ρethanoland
the porosity can be calculated using the following equation,Porosity=(Wf−Wi)/ρethanolV2−V1

2.3. Biocompatibility evaluation
2.3.1. Establishment of BFPSC cultures and their characterization according to international society for
cellular therapy (ISCT) criteria
Buccal fat pad tissues were harvested from vestibular incision distal to the maxillary second molar of healthy
volunteers. The tissues were digested in a solution of 3 mg/ml type I collagenase for 1 h at 37°C. Then, the cells
were re-suspended in stem cell growth medium containing Dulbecco’s Modified Eagle’s medium (DMEM,
Thermo Fisher Scientific) supplemented with 15% Fetal Bovine Serum (FBS, Thermo Fisher Scientific) and 1%
penicillin/Streptomycin (Life Technologies) and cultured in T-25 flasks under 5% CO2 at 37°C. The cells were subcultured at 80% confluency using 0.25% trypsin-EDTA (Life Technologies) at a ratio of 1:3 until desired passage
(P3)was obtained.
In order to confirm whether the isolated/cultured BFPSCs display the Mesenchymal Stem Cell (MSC) phenotype,
the cells were subjected to flow cytometry analysis for expression of positive (CD44, CD90, CD73 and CD105)
and negative (CD45 and CD34) MSC markers. Briefly, cells at P3 were treated with 0.05% trypsin-EDTA. The
harvested cells were centrifuged and then, cell pellets were re-suspended at concentration of 105 per sample in
PBS and incubated for 30 min at 4°C in the dark room with antibodies. After incubation time, cells were washed
with Phosphate-Buffered Saline (PBS, Sigma-Aldrich). Analysis was next performed using flow cytometer
(Applied Biosystems). The positive control expression was defined as the level of fluorescence greater than 99%
of the corresponding unstained cells.
Moreover, the multilineage differentiation capability of BFPSCs was also evaluated. To do this, the cells were
cultured in 12-well plates, at concentration of 104 cells/well, in various differentiation mediums. For
osteogenesis, cells were cultured for 14 days in medium consisting of DMEM-LG (Thermo Fisher Scientific), 10%
FBS, 50 μg/mL ascorbate-2 phosphate (Thermo Fisher Scientific), 10−8 M dexamethasone (Sigma-Aldrich), and
10 mM β-glycerophosphate (Sigma-Aldrich). Alizarin Red staining (Sigma-Aldrich) was administrated to assess
the mineral deposition. For adipogenesis, cells were cultured for 14 days in medium consisting of DMEM-LG,

10% FBS, 50 μg/mL ascorbate-2 phosphate, 10−7 M dexamethasone, and 50 μg/mL indomethacin (SigmaAldrich). The Cells then are stained with Oil Red O (Sigma-Aldrich) to evaluate adipogenesis. Chondrogenesis
medium contained DMEM-LG, 10% FBS, 1 μM ascorbate-2 phosphate, 10−7 M dexamethasone, 10 ng/mL TGF-β1
(Sigma-Aldrich) and 1% sodium Pyruvate (Sigma-Aldrich). Chondrogenic differentiation was assessed by
toluidine blue staining (Sigma-Aldrich) after 14 days.

2.3.2. Cell seeding and preparation of cell-scaffold constructs
PDLLA/β-TCP scaffolds at the size of 8 mm × 8 mm were fabricated with 3D printer and used for in vitro studies.
A total of 5 × 105 cells were seeded into each scaffold. Cell-scaffold constructs were then incubated in stem cell
growth medium in 48-well plates for the designated time according to different experimental purposes.

2.3.3. Evaluation of cell attachment
Cell attachment was evaluated using SEM (Akishima) after 5 days incubation in stem cell growth medium.
Briefly, the constructs were sectioned and fixed with 1.5% glutaraldehyde (Merck) in a 0.1 M Sodium Cacodylate
(CAC) (Sigma-Aldrich) buffer. Next, they were post-fixed in 1% osmium tetroxide (Sigma-Aldrich) in 0.1 M CAC
buffer for another 1 h, followed by dehydrating through an ethanol series (30%–100%) and drying in
hexamethyldisilazane (Sigma-Aldrich). The samples were then coated with gold and subjected to SEM imaging.
Scaffolds without cells but cultured and processed under the same conditions were also examined by SEM as
controls.

2.3.4. Evaluation of cell viability/proliferation
Cell proliferation/viability was evaluated after 24 h, 3 and 5 days incubation in stem cell growth medium using 3(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma-Aldrich) and DNA counting assay. For
MTT assay, cell culture mediums were replaced with fresh medium containing 10% MTT solution (5mg/ml). Then
the cells were incubated for 2 h protected from light at 37°C and 5% CO2. Next, mediums were replaced with
DMSO (Sigma-Aldrich) and shake to ensure complete solubilization. The optical density is read at 570 nm in ELSA
reader (BioTek). For DNA counting, the constructs first washed with PBS in order to remove any dead cells and
detached cells, then they were dissolved in 1ml Tryzol (Life Technologies) at room temperature for 10 min
followed by phase separation using chloroform. Then, DNA was isolated by precipitation. DNA concentration
was measured using Nano drop (Thermo Fisher Scientific).
Cell viability, as well as, cell attachment was also evaluated using live/dead and DAPI staining (Sigma-Aldrich)
after 5 days incubation in stem cell growth medium. To do live/dead assay, the constructs were incubated with a
mixture of Cell TrackerTM green (5-chloromethylfluorescein diacetate and Ethidium Homodimer (EH-1) for 1 h at
room temperate. The viable cells (green fluorescence) and dead cells (red fluorescence) were detected with a
fluorescence microscope. For DAPI staining, the constructs first were fixed with 4% glutaraldehyde (Merck)
followed by DAPT staining for 10 s. Then cells were monitored with a fluorescence microscope.

2.3.5. Evaluation of osteogenic differentiation
The osteogenic differentiation capability of cells seeded on the constructs was also determined using Alkaline
Phosphatase (ALP) activity, after 7 and 14 days induction in osteogenic medium. for ALP activity assay,
constructs were rinsed with PBS and homogenized in lysis buffer (pH 7.5, 10 mMTris–HCl, 1 mM MgCl2, and
0.05% Triton X-100). The resulting mixture was then centrifuged at 12,000 rpm for 10 min at 4°C. The cell lysate
was mixed with p-nitrophenol phosphate substrate solution (Sigma-Aldrich) and alkaline buffer solution (SigmaAldrich). After incubation at 37°Cfor 15 min, the above mixture was added to 0.5 N NaOH to stop the reaction
and the absorbance at 405 nm was measured using ELISA reader (BioTek).
The osteogenic differentiation of the cells seeded on the constructs was also determined by evaluation of
osteogenic markers using Real time RT-PCR. The expression of ALP, BMP2, COL I and RUNX2 was evaluated as

follows: First, constructs are dissociated with Tryzol (Life Technologies) reagent followed by RNA isolation. Then
the quantity and quality of isolated RNA was determined using Nanodrop spectrometer (Thermo Fisher
Scientific). RNA was reverse-transcribed into cDNA. Reverse transcription was performed at 37°C for 50 min
followed by heating at 70°C for 15 min to inactivate the reaction. cDNA templates were used for SYBR Green
real-time PCR to detect cycle threshold (CT) values with Applied Biosystems’ Real-Time PCR System. The CT
values were normalized to GAPDH to calculate ΔCT. RGE was calculated with the formula 2-ΔΔCT using the control
as the reference (RGE = 1). Primer sequences are given at Table 1.
Table 1. Primer sequences used for Real-time PCR.
Primer name
ALP/F
ALP/R
BMP2/F
BMP2/R
COL1A1/F
COL1A1/R
RUNX2/F
RUNX2/R

Accession number Sequences 5ʼ-3ʼ
NM-001177520.2 AGGACGCTGGGAAATCTGTG
ATGAGCTGGTAGGCGATGTC
NM-001200.4
GGACGCTCTTTCAATGGACG
AGCAGCAACGCTAGAAGACAG
NM-000088.3
TGGAGCAAGAGGCGAGAG
ATCACCCTTAGCACCATCG
NM-001015051.3 CGGAATGCCTCTGCTGTTATG
AGGATTTGTGAAGACGGTTATGG

2.3.6. Statistical analysis
All experiments was conducted in triplicated. The results are expressed as mean ± standard deviation. Two-way
analysis of variance (ANOVA) were conducted in SPSS software (version 15.0; SPSS, Chicago, IL). Differences
were considered with a confidence interval 95% (P value ≤ 0.05) for all analyses.

3. Results
3.1. Physicomechanical characterization
3.1.1. Microstructure analysis
Photographs of top view and lateral view the 3D printed PDLLA (Fig. 1A and B) and PDLLA/β-TCP (Fig. 1C and D)
scaffolds shows that the scaffolds are porous with interconnected pores and reproducible pattern. It is worthy of
note that with the designed inner structure (90° shift between layers) pores are also formed in the z-axis, which
is very crucial for clinical applications as facilitates infiltration of cells to the scaffold.

Fig. 1. Photograph of the (A) top, (B) lateral view of PDLLA scaffolds, and (C) top, (D). lateral view of PDLLA/β-TCP
scaffolds printed with 3D Bioplotter (scale bar 2 mm).

The fabricated scaffolds were scanned using the LEXT OLS4000 3D Laser Measuring Microscope (Olympus). As
can be seen in Fig. 2A–D, scaffolds have almost identical microstructure with smooth surface topography. The
width of the pores in both PDLLA and PDLLA/ß-TCP scaffolds was measured to be 320 μm and the width of
strands was found to be 400 μm. The pore size in the lateral side of scaffolds was measured to be in the range of
200–250 μm.

Fig. 2. Micrographs of the inner structure of (A) top, (B) lateral view of PDLLA scaffolds, and (C) top, (D) lateral
view of PDLLA/ß-TCP scaffolds at 5x magnification (scale bar x: 550 μm, y: 450 μm).

3.1.2. Porosity measurement
As summarized in Table 2, porosity of PDLLA/β-TCP scaffolds were measured to be slightly higher than the 3printed scaffolds based on pristine PDLLA. Such observation is attributed to the altered extruded melt viscosity
after incorporation of β-TCP. In fact, viscosity increase originates from interaction of PDLLA chains with β-TCP
particles. This effect is also evident based on differential scanning calorimetry results, which showed higher glass
transition temperature for PDLLA/β-TCP compared to PDLLA. As printing condition including temperature,
pressure, and speed kept constant to fabricate both PDLLA and PDLLA/β-TCP scaffolds, thinner strands were
extruded for the composite formulation which resulted in relatively higher porosity. The laser microscope
images confirm the thinner strands for PDLLA/β-TCP compared to pure PDLLA scaffolds.
Table 2. Porosity, Young’s Modulus, and compressive strength of 3D printed scaffolds.
Scaffolds
Porosity (%) Young’s modulus (MPa) Compressive strength (MPa)
PDLLA
57.1 ± 2.6
447.2 ± 53.7
24.1 ± 3.9
PDLLA/b-TCP 55.6 ± 1.5
514.5 ± 34.3
32.3 ± 2.4

3.1.3. Fourier transform infrared spectroscopy (FTIR) analysis
FTIR patterns of β-TCP, PDLLA and PDLLA/β-TCP are depicted in Fig. 3. By comparing the typical absorption
bands of PDLLA and β-TCP, peaks appeared at 790 and 1500–1800 cm-1 that are thought to be the RCOO-Ca
absorption bands. In order to reach composite scaffolds with improved mechanical properties, the interface
between the PDLLA matrix and the dispersed phase i.e., β-TCP particles should be strong to enable transferring

the stress of mechanical loading from polymer to the bioceramic phase. Interactions among PDLLA chains and βTCP particles results in improved Young’s Modulus and compressive strength of composite scaffolds.

Fig. 3. FTIR spectrum of PDLLA, β-TCP powder and PDLLA/β-TCP composite.

3.1.4. Differential scanning calorimetry analysis
The thermal properties of PDLLA/β-TCP composite scaffolds were examined by differential scanning calorimetry
(DSC) analysis. As shown in Fig. 4, the incorporation of β-TCP in PDLLA matrix resulted in increased glass
transition temperature (Tg). The increase in Tg is a result of interactions among organic and inorganic phase in
composite that cause hindered dynamic of polymer chains. This finding is well consistent with the FTIR analysis.

Fig. 4. The DSC thermograms of PDLLA and PDLLA/β-TCP composite scaffolds.

3.1.5. Evaluation of mechanical properties
As summarized in Table 2, PDLLA/β-TCP scaffolds exhibited increased Young’s Modulus and compressive
strength compared to the pristine PDLLA scaffolds. It is worthy of note that although the composite scaffolds
possess higher porosity, but they showed superior mechanical strength.

3.2. BFPSC characterization according to ISCT criteria

Mesenchymal stem cell from BFP showed fibroblastic-shaped morphology (Fig. 5A). After a 3-week incubation
under adipogenic conditions, BFPSCs showed the formation of neutral lipid vacuoles, visualized by staining with
Oil-red O (Fig. 5B). After 14 days of incubation under chondrogenic conditions, the development of cartilage
matrix from BFPSCs was shown by staining the proteoglycans with Toluidine Blue (Fig. 5C). Also, calcium
deposition was shown by Alizarin red staining after 14 days induction in osteogenic medium (Fig. 5D).

Fig. 5. BFPSC characterization according to ISCT criteria. (A–D) Multilineage differentiation capabilities of BFPSCs
after 14 days in basal medium (A), adipogenic (B), chondrogenic (C) and osteogenic (D) medium. (E) Flow
cytometry analysis of BFPSCs for mesenchymal stem cell surface markers.
In order to confirm whether the isolated/cultured BFPSCs display the MSC phenotype, cells were subjected to
flow cytometry analysis for expression of positive CD44, CD90, CD73 and CD105 and negative (CD45 and CD34)
MSC markers. The result showed that more than 95% of this cell population were positive for CD44, CD90, CD73
and CD105, MSC-surface markers, whereas they were negative for CD45 and CD34, hematopoietic markers
(Fig. 5E).

3.3. Biocompatibility evaluation
3.3.1. Evaluation of cell attachment
The suitability of the 3D structure of scaffolds for cell seeding was assessed by observing cell adhesion using SEM
imaging. SEM microphotographs after 5 days showed the attachment of BPSCs to the entire scaffold surface
(Fig. 6C–F).

Fig. 6. BFPSC attachment on PDLLA/β-TCP. (A, B) SEM micrographs of scaffold at different magnifications. (C–F)
SEM micrographs of scaffold loaded with BFPSCs after 5 day at different magnifications.

3.3.2. Evaluation of cell viability/proliferation
The proliferation/viability of BFPSCs were first monitored and quantified after 24h, 3d and 5 days by MTT and
DNA counting assay (Fig. 7A and B). Both MTT and DNA counting assay showed the significant growth rate of
BFSCs on scaffolds from day 1 to 5. Live-dead assay and DAPI staining were also confirmed the cell viability and
attachment of BFSCs on PDLLA/β-TCP scaffold (Fig. 7C–E).

Fig. 7. BFPSC proliferation/viability on PDLLA/b- TCP. (A) MTT assay after 24h, 3d and 5d in stem cell culture
medium. (B) DNA counting assay after 24h, 3d and 5d in stem cell culture medium. (C, D) Live-dead assay after
5days. (E) DAPI staining after 5days. ∗ indicates significant difference at 0.05.

3.3.3. Evaluation of osteogenic differentiation

ALP activity of BFPSCs cultured on PDLLA/β-TCP scaffold significantly increased from day 7 to day 14 in
osteogenic induction medium as compared to cells cultured on PDLLA/β-TCP in basal medium (Fig. 8A). Using
Real time RT-PCR the expression of four osteogenic genes, ALP, BMP2, COL I and RUNX2 has been evaluated at
both early (7 days) and later stage (14 days) of osteogenic differentiation (Fig. 8B–E). The results indicate that
the expression of given genes significantly increase at both time points as compared to control.

Fig. 8. Osteogenic capability of BFPSCs on PDLLA/β-TCP. (A) ALP activity assay after 5days in basal medium, 7 and
14days in osteogenic medium. (B–E) Expression of osteogenic-related markers after 5days in basal medium, 7
and 14days in osteogenic medium as determined by Real time RT-PCR. ∗ indicates significant difference at 0.05.

4. Discussion
The preparation of composite scaffolds, containing both organic and inorganic parts, close to the structure of
the native bone, would help to fulfill the requirements for bone regeneration in load-bearing areas [4,5]. In this
study, PDLLA/β-TCP scaffolds were fabricated using CAD and 3D print technology. Then, the physicomechanical
characteristics of the customized scaffolds were investigated to see if they match with natural bone properties.
Also, the in vitro biological characteristics of manufactured scaffolds in conjugation with BFPSCs in order to
evaluate their biocompatibility and osteogenic differentiation capacity were evaluated.
We took advantage of using a 3D printing technology in order to manufacture scaffolds with interconnected
porous structure and a regular and reproducible morphology of the pores which has been shown to be essential
for continuous bone regeneration [28,29]. A part from fabricating the controlled interconnected porous
structure, this technology allowed to fabrication of scaffold with pore size range of 320–400 μm. However, there
is still a controversy within the literature regarding the scaffold optimal pore size for ideal bone regeneration
[[28], [29], [30], [31]]. Some studies recommended higher pore size dimeter for an ideal bone ingrowth and
vascularization [32,33]. However, others showed that increasing the pore diameter would significantly
diminished scaffold mechanical strength [5,31,32]. A mechanical stability of a scaffold not only related to the
pore size, but also significantly affected by porosity percentage [5,34]. A study by Bose et al., on different
porosity of β-TCP scaffolds showed that compressive strength of the scaffolds decreased with increasing
porosity percentage [35]. In this study, fabricated scaffolds have the porosity of 55% which is well-fitted to the
lower range of natural cancellous bone, i.e.50–90%. However, considering the fact that fabricated scaffolds have
proper mechanical properties, having the low porosity percentage of scaffolds are acceptable.
Mechanical properties of 3D-printed scaffolds are decisive on their biomechanical performance in tissue
engineering. Both composition and porosity affect the mechanical features of scaffolds. Comparing the values of

strength and compressive modulus of 3D-printed scaffolds with those of for the cancellous bone (compressive
strength: 2–12 MPa, compressive modulus: 50–500 MPa), reveals 3D-printed PDLLA-based scaffolds as
promising matrices for cancellous bone regeneration. The composite of ceramic, β-TCP, and polymer, PDLLA,
phases has been combined the desired properties of both materials [13,15,[36], [37], [38], [39], [40], [41]]. To
achieve this, most studies have been used the equal ration of PDLLA and ceramic materials [[2], [3], [4], [5],17].
A study by Lin et al., has been shown that increasing TCP from 30- 50 wt% in composite scaffold improved both
mechanical strength and elastic modulus [3]. However, Bae EB et al., claimed that increasing the percentage of
β-TCP in a composite scaffold would increase the viscosity which significantly affects the scaffold printing speed.
Hence, in order to balance between β-TCP content and printing rate, they kept the percentage of polymer phase
higher [5]. Similarly, we kept the ration of polymer phase slightly higher that ceramic phase i.e., 60% PDLLA vs.
40% β-TCP, in order to have the best compromise between printing process and scaffold mechanical properties.
Degradation of PDLLA causes an acidic environment in the implantation site of the scaffold which may result in
inflammatory responses. In the current research, β-TCP as a biocompatible ceramic was incorporated into the
polyester scaffold to not only conduct osteogenesis, but also buffer the subsequent acidic environment in the
vicinity of the composite scaffold.
As widely reported in previous studies, incorporation of β-TCP in composite scaffolds significantly enhance their
mechanical properties [2,3,6]. Similarly, in this study addition of 40% β-TCP in PDLLA composite significantly
increased both compressive strength and elasticity of the scaffold. In compare to study by Linder M et al., and
Zhang LF et al., we used the lower ratio of β-TCP in composite scaffold (40% vs 50%) [2,6], however, higher
compressive strength is achieved. Here, the comparative strength is higher than cancellous bone with a
compressive strength in the range of 2–20 MPa [2]. however, compared to compressive strength of human
cortical bone (70-280MPA), the fabricated scaffold still showed lower stability [4]. In several studies they
reported the fabricated ceramic-polymer scaffolds with much higher mechanical strength, compared to our
composite scaffold, however; they significantly compromised the scaffold porosity which is ultimately affecting
the growth of new bone [5,9,23].
Apart from physicomechanical properties resembling natural bone structure, an ideal bone graft material should
have proper biocompatibility and osteogenic differentiation capacity properties [5,23].
A fabricated composite material in this study has been extensively evaluated for their ability to support cellular
attachment, proliferation, as well as osteogenic differentiation/induction. BFPSCs have been chosen for these
analyses due to their well-documented potentials for bone tissue engineering [42,43]. Similar to previous studies
[[44], [45], [46]], here in incorporation of β-TCP support both attachment and proliferation of BFPSCs loaded on
composite materials. Moreover, this composite material showed the proper osteogenic differentiation capacity
as confirmed by both ALP and gene expression analysis.
Further in vivo implantation of this fabricated scaffold is recommended in order to evaluate its potential for
bone regeneration. Moreover, in order to translate the finding of this study in clinical setting, fabrication of this
scaffold with GMP-grade materials is recommended.

5. Conclusion
Hence, the 3D printed customized scaffold in this study, with regard to proper pore size, porosity, mechanical
strength, material composition, biocompatibility, and osteogenic differentiation capacity demonstrate a
promising composite material for the purpose of the bone tissue engineering.
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